Sign in
TerminatedNo phase

Functional Strength Training and Neuromuscular Electrical Stimulation in Severe Acute Exacerbations of COPD

Key facts

Who runs it
Hasselt University
Where
Belgium1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
35 people enrolled
Started
1 Jun 2022
Ended
1 Dec 2023
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Functional strength training
  • NMES
  • Daily medical treatment (e.g., oxygen, medrol, duovent, azitromycine)
  • Routine physiotherapy
Record updated
15 September 2025
Why it stopped
The anticipated intervention could not be delivered due to low admission time

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • hospitalised due to an AECOPD according to the Global Initiative for Chronic Obstructive Lung Disease criteria
  • included within 48h of hospital admission
  • able to provide informed consent
  • dutch speaker

Who cannot take part

  • hospitalization in the previous month
  • unstable cardiovascular disease
  • significant musculoskeletal or neuromuscular impairment that precludes the performance of the tests or participation in the study
  • signs of cognitive impairment
  • current neoplastic or immunological disease
  • implantable electronic devices (e.g., pacemaker, implantable cardioverter defibrillator [ICD], cardiac resynchronization therapy [CRT] device)
  • need for mechanical ventilation or admission in the intensive care unit
  • sensitivity alterations

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Chronic obstructive pulmonary disease (COPD) is highly prevalent and frequently punctuated by severe acute exacerbations (AECOPD), defined as a temporary worsening of symptoms which leads to hospitalisation. AECOPD result in physical inactivity, muscle weakness and decreased exercise capacity, which impacts negatively on patients' health status, and increases patients' susceptibility for new exacerbations and death. To date, light aerobic exercises, such as early mobilisation and low-intensity ambulation, have become part of standard of care during severe AECOPD. Nevertheless, additional strength training using neuromuscular electrical stimulation and functional exercises, which have been shown to prevent skeletal muscle dysfunction whilst inducing minimal stress in the ventilatory system, might be of added value to optimize patients' functional performance and symptoms during activities at discharge.

Read full original descriptionShow less

Therefore, this randomized controlled trial aims to evaluate the effectiveness of additional functional strength training and neuromuscular electrical stimulation on top of standard of care during hospitalisation for an AECOPD to enhance functional performance, symptoms of dyspnoea and fatigue during activities, and readmission rate.

The 2 groups in the trial

  • Functional strength training + NMESTreatment being tested

    The experimental group will receive the standard of care plus functional strength training and quadriceps neuromuscular electrical stimulation. Functional strength training will include lower limb (e.g. rising from chair, heel rises) and upper limb (e.g. push-ups from the chair and against the wall) exercises for 15 min/day. Target levels of dyspnoea and/or perceived exertion will be 4 to 6 in the modified Borg scale. For neuromuscular electrical stimulation, electrodes will be placed longitudinally on the vastus intermedius and vastus medialis and a symmetric biphasic pulse waveform, with a pulse duration of 400ms, a frequency of 50Hz, in cycles of 8s of contraction and 20s of rest, will be used for 30min/day. The highest intensity tolerated by the patient will be used and intensity will be increased every time the patient feels comfortable with increasing the intensity. The device Compex Pro Rehab (CE-0473) will be used.

    Treatment: Functional strength training, NMES, Daily medical treatment (e.g., oxygen, medrol, duovent, azitromycine), and Routine physiotherapy

  • Standard of careExisting treatment, for comparison

    The standard of care group will receive the common treatment delivered at the hospital, i.e., routine medical treatment and daily sessions of approximately 15 minutes consisting of airway clearance techniques and breathing exercises upon indication, mobilization, and low-intensity daily walking/cycling exercise (5 to 10 minutes) according to patients' tolerance.

    Treatment: Daily medical treatment (e.g., oxygen, medrol, duovent, azitromycine) and Routine physiotherapy

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effects of Functional Strength Training and Neuromuscular Electrical Stimulation During Hospitalisation for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: a Randomised Controlled Trial
Record updated
15 September 2025